Skip to main content
EuroIntervention logoLink to EuroIntervention
. 2021 Sep 20;17(7):586–587. doi: 10.4244/EIJ-D-20-00325

A novel technique for percutaneous mitral balloon valvuloplasty

New technique for percutaneous mitral valvuloplasty

Cristina Aurigemma 1, Francesco Burzotta 2,3,*, Enrico Romagnoli 4, Carlo Trani 5,6
PMCID: PMC9725015  PMID: 32624459

The Inoue technique is the most widely practised technique for percutaneous mitral valvuloplasty (PMV), but its equipment and technical steps differ from other contemporary structural heart interventions. This has made PMV cumbersome in countries with a low prevalence of rheumatic disease. We developed a novel technique based on the original combination of tools commonly used for other structural heart interventions.

The procedure is performed using the femoral vein to perform the PMV and the radial artery for the introduction of a pigtail catheter in the left ventricle (LV) to monitor the procedure. The key procedure steps (Figure 1) are as follows.

Figure 1.

Figure 1

Strengths of the novel technique for percutaneous mitral valvuloplasty.

– Transseptal puncture under transoesophageal echocardiographic (TEE) guidance (Figure 1A, Figure 1B).

– The 12 Fr bidirectional steerable guiding sheath (GS) facilitates the crossing through the stenotic orifice allowing the deflection of its tip to face towards the mitral valve (MV) orifice (Figure 1D, Moving image 1).

– Conventional valvuloplasty balloon inflation under rapid pacing to stabilise the balloon position (Figure 1E, Moving image 2).

– Rapid pacing performed non-invasively by directly stimulating the LV (by clipping a crocodile electrode of an external pacemaker onto the guidewire and the other crocodile electrode onto a percutaneous pacing pad located on the patient’s leg1) (Figure 1F).

– Choose the first balloon size according to the virtual intercommissural distance of the MV as measured by three-dimensional echocardiography (instead of height-based balloon reference) to limit severe mitral regurgitation risk (Figure 1C).

– Evaluation of the result by both TEE and invasive gradient control (easily taken by recording left atrial pressure from the GS and LV pressure from the pigtail catheter).

– Possible repeat balloon inflations with the same balloon or with stepwise increased balloon sizes without valve re-crossing in unsuccessful results.

A consecutive series of seven patients with symptomatic mitral valve stenosis has been treated with this novel technique in our centre. In three cases a second (2 mm diameter increase) balloon was needed. The PMV was successful in all patients.

In conclusion, we propose a novel technique with the following strengths: easy antegrade MV crossing, continuous access to the LV over the wire, easy measurement of invasive transmitral pressure gradient monitoring to guide the procedure.

F. Burzotta discloses having been involved in advisory board meetings or having received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. C. Trani discloses having been involved in advisory board meetings or having received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. C. Aurigemma has been involved in advisory board activities or has received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. E. Romagnoli has been involved in advisory board activities or has received speaker’s fees from Abbott, Abiomed, and Medtronic.

Supplementary data

Moving image 1

Pigtail crosses the stenotic orifice. The pigtail crossing is facilitated by deflection of the bidirectional steerable guiding sheath.

Moving image 2

Conventional valvuloplasty balloon inflation under rapid ventricular pacing, performed using non-invasive left ventricular stimulation by the stiff guidewire.

Acknowledgments

Conflict of interest statement

F. Burzotta discloses having been involved in advisory board meetings or having received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. C. Trani discloses having been involved in advisory board meetings or having received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. C. Aurigemma has been involved in advisory board activities or has received speaker’s fees from Abbott, Abiomed, Medtronic and Biotronik. E. Romagnoli has been involved in advisory board activities or has received speaker’s fees from Abbott, Abiomed, and Medtronic.

Contributor Information

Cristina Aurigemma, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Francesco Burzotta, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica Del Sacro Cuore, Rome, Italy.

Enrico Romagnoli, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Carlo Trani, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica Del Sacro Cuore, Rome, Italy.

References

  1. Burzotta F, Aurigemma C, Romagnoli E, Shoeib O, Russo G, Zambrano A, Verdirosi D, Leone AM, Bruno P, Trani C. A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020;96:459–70. doi: 10.1002/ccd.28697. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Moving image 1

Pigtail crosses the stenotic orifice. The pigtail crossing is facilitated by deflection of the bidirectional steerable guiding sheath.

Moving image 2

Conventional valvuloplasty balloon inflation under rapid ventricular pacing, performed using non-invasive left ventricular stimulation by the stiff guidewire.


Articles from EuroIntervention are provided here courtesy of Europa Group

RESOURCES